title: Recurrence of strongyloides stercoralis infection in a patient with Hansen's disease: a case report.
abstract: In patients with immunosuppressive disorders, S. stercoralis infection may develop into a hyperinfection syndrome which, on rare occasions, may be a life-threatening condition. Therapy of S. stercoralis infection with thiabendazole has been limited, due to its numerous side effects, and has been replaced by albendazole and ivermectin. The present case report describes a case of Strongyloides Hyperinfection Syndrome (SHS) in a patient with Hansen's disease and lack of response to first-line anthelmintic treatment. A 38 year-old man was diagnosed as having borderline lepromatous leprosy. He developed Erythema Nodosum Leprosum and was treated with thalidomide and prednisone. In May 2010 he was diagnosed with S. stercoralis infection and was treated with albendazole. One year later, the stool examination showed continued presence of S. stercoralis larvae. He was treated with ivermectin (6 mg) in a double dose (given 1 month apart) which resulted in larvae excretion clearance. The absence of infection was confirmed three times during a 1 year followup period by stool examination and non-detection of anti-S. stercoralis IgG levels.
authors: Joelma Nascimento
authors: JN
authors: De Souza
authors: Paulo Roberto Lima
authors: PR
authors: Machado
authors: Márcia Cristina Aquino
authors: MC
authors: Teixeira
authors: Neci Matos
authors: NM
authors: Soares
mesh_terms: D000328:Adult; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000150:complications*; D008297:Male; D017171:Strongyloides stercoralis / Q000187:drug effects / Q000302:isolation & purification / Q000502:physiology*; D013322:Strongyloidiasis / Q000188:drug therapy / Q000209:etiology / Q000469:parasitology*
chemical_list: D000871:Anthelmintics